Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Action Potential Venture Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Action Potential Venture Capital

Action Potential Venture Capital

Operating

APVC, GSK's venture fund, invests in next-gen neuromodulation devices for targeted bioelectronic medicine.

Location
Palo Alto, CA, US
Founded
2013
Firm
Compare
Portfolio
Employees
Website

Investments

Presidio Medical
Presidio Medical

Total Raised

$102M

Rounds

3

Series C$72MJune 2023
Series B$30MJuly 2020
Series AJanuary 2018
Setpoint Medical
Setpoint Medical

Total Raised

$344M

Rounds

12

Series Unknown$80MJanuary 2023
Series Unknown$64MJanuary 2021
Series Unknown$15.7MSeptember 2019
Series D$30MAugust 2017
Series C$15MSeptember 2015
Series C$27MAugust 2013
Onc.AI
Onc.AI

Total Raised

$31M

Rounds

2

Series A$25MJanuary 2023
Alpheus Medical
Alpheus Medical

Total Raised

$30M

Rounds

2

Series A$14MNovember 2022
Series A$16MNovember 2021
MicroTransponder
MicroTransponder

Total Raised

$115.1M

Rounds

12

Series E$73MJune 2022
Neuspera Medical
Neuspera Medical

Total Raised

$111.9M

Rounds

4

Series C$65MJuly 2021
Series B$12MFebruary 2019
Series B$26MJanuary 2018
Exo
Exo

Total Raised

$307.6M

Rounds

7

Series B$40MAugust 2020
Cvrx
Cvrx
Public

Total Raised

$390.6M

Rounds

10

Private Equity$50MJuly 2020
Series G$93MAugust 2019
Axon Therapies
Axon Therapies

Total Raised

$3.3M

Rounds

3

Series AJuly 2019
Cala Health
Cala Health

Total Raised

$148.3M

Rounds

4

Series C$50MMay 2019
Series B$18MFebruary 2016